Home Page

STOCKHOLM, Sept. 15, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today updated interim efficacy and safety data from the ongoing pivotal Phase 2 study, HORIZON, at the 17th International Myeloma Workshop (IMW) meeting in Boston, Massachusetts, USA. The... Read more ››

PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced emerging durability data in patients with wet age-related macular... Read more ››

BOSTON, Sept. 15, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized Phase 2 GRIFFIN (Read more ››

FOOTHILL RANCH, Calif., Sept. 15, 2019 /PRNewswire/ -- TAE Life Sciences, a company pioneering a new cancer treatment... Read more ››

TEMPE, Ariz., Sept. 15, 2019 /PRNewswire/ -- Nocira, LLC announces its fourth and fifth US Patents, US 10,251,790 and 10,278,868, issued by the U.S. Patent and Trademark Office related to its novel approach for treating headaches via ear pressure modulation.

PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos((TM)) therapy, an Adaptive Intelligence((TM)) solution. Ethos therapy is an artificial intelligence... Read more ››

DENVER, Sept. 13, 2019 /PRNewswire/ -- A new, two-minute screening technique could help save cats from dying prematurely of heart disease. Read more ››

NEW DELHI, Sept. 13, 2019 /PRNewswire/ -- Binod Chaudhary, Chairman of CG Corp Global, and other notable speakers and presenters from different corporations will be sharing their expert opinions about business and the wellness industry in Asia during the annual Global Wellness Summit to be held... Read more ››

SYDNEY, Sept. 13, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) is pleased to announce that it has been named as a winner in the 2019 ANZLF Trans-Tasman Innovation & Growth Awards.

NEUCHATEL, Switzerland, Sept. 13, 2019 /PRNewswire/ -- MBP Solutions, the pioneering and world-leading provider of biological by-product outsourcing services (OMBP), today celebrates its 20(th) anniversary in business and revealed its new, updated corporate identity - developed to support... Read more ››

STAINES-UPON-THAMES, United Kingdom, Sept. 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company,... Read more ››

DUBLIN, Sept. 13, 2019 /PRNewswire/ -- X-BOLT Orthopaedics, a leading medical device company, today announced preliminary results from the largest ever multi-centre randomised controlled trial comparing extracapsular hip fracture fixation devices, known as World Hip Trauma Evaluation 4 (WHITE4).... Read more ››

SEATTLE and VANCOUVER, British Columbia, Sept. 13, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that two presentations... Read more ››

STANFORD, Calif., Sept. 13, 2019 /PRNewswire/ -- On Monday, September 16 at Stanford Medical Center and leading centers of medicine across the U.S., doctors, nurses, medical students, EMTs, and other healthcare professionals and supporters will stand together for the second year to accept the... Read more ››

WASHINGTON, Sept. 13, 2019 /PRNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Officer of Inspector General Read more ››